CYTH - Cyclo Therapeutics, Inc.

QQQ $ 476.00 $ 5.61 (1.19 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 96.60 $ -1.04 (-1.07 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 0.7477

Open

Bid

$ 0.63 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.70 - $ 2.12

Volume

138,224

Average Volume

Market Cap

21.46M

Beta (5Y Monthly)

$ -0.31

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-18-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-12-2023	03-31-2023	10-Q
7	03-17-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-11-2022	12-31-2021	10-K
12	11-15-2021	09-30-2021	10-Q
13	08-16-2021	06-30-2021	10-Q
14	05-14-2021	03-31-2021	10-Q
15	03-12-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-14-2020	06-30-2020	10-Q
18	05-15-2020	03-31-2020	10-Q
19	03-30-2020	12-31-2019	10-K
20	11-14-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-15-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-14-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	04-16-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-11-2017	06-30-2017	10-Q
30	05-12-2017	03-31-2017	10-Q
31	03-17-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-12-2016	06-30-2016	10-Q
34	05-16-2016	03-31-2016	10-Q
35	03-30-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-14-2015	06-30-2015	10-Q
38	05-15-2015	03-31-2015	10-Q
39	03-27-2015	12-31-2014	10-K
40	11-14-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

this-hershey-analyst-turns-bearish-here-are-top-5-downgrades-for-tuesday

This Hershey Analyst Turns Bearish; Here A...
08/27/2024 13:00:52

Maxim Group Downgrades Cyclo Therapeutics ...
08/27/2024 12:32:28

Maxim Group analyst Jason McCarthy downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Hold.

Ascendiant Capital Maintains Buy on Cyclo ...
08/26/2024 10:10:17

Ascendiant Capital analyst Lucas Ward maintains Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and lowers the price target from...

HC Wainwright & Co. Downgrades Cyclo Thera...
08/23/2024 11:23:33

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Cyclo Therapeutics (NASDAQ:CYTH) from Buy to Neutral and l...

nasdaq-down-over-200-points-williams-sonoma-shares-tumble-after-q2-results

Nasdaq Down Over 200 Points; Williams-Sono...
08/22/2024 18:47:30

gold-down-over-1-us-initial-jobless-claims-increase

Gold Down Over 1%; US Initial Jobless Clai...
08/22/2024 16:16:23

dow-jumps-100-points-bjs-wholesale-earnings-top-estimates

Dow Jumps 100 Points; BJ's Wholesale Earni...
08/22/2024 13:54:09

Rafael And Cyclo Therapeutics Have Agreed ...
08/22/2024 10:52:33

On consummation of the merger, Rafael will issue Class B shares to Cyclo Therapeutics' shareholders, based on an exchange r...

HC Wainwright & Co. Reiterates Buy on Cycl...
08/16/2024 16:12:53

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

Cyclo Therapeutics Q2 EPS $(0.21) Misses $...
08/15/2024 13:03:11

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of ...

Cyclo Therapeutics Receives Grant Notice F...
07/29/2024 13:05:50

Cyclo Therapeutics Has Been Granted Europe...
07/22/2024 17:02:35

https://register.epo.org/application?number=EP19805439

HC Wainwright & Co. Reiterates Buy on Cycl...
05/31/2024 10:17:42

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Cyclo Therapeutics (NASDAQ:CYTH) with a Buy and maintains ...

Cyclo Therapeutics Completes Last Patient ...
05/30/2024 13:04:47

TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and...

Cyclo Therapeutics Q1 2024 GAAP EPS $(0.15...
05/16/2024 12:29:24

Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(...

HC Wainwright & Co. Initiates Coverage On ...
05/01/2024 10:13:28

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rat...

Ascendiant Capital Initiates Coverage On C...
04/22/2024 09:40:07

Ascendiant Capital analyst Lucas Ward initiates coverage on Cyclo Therapeutics (NASDAQ:CYTH) with a Buy rating and announces...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

Cyclo Therapeutics Receives Decision To Gr...
04/02/2024 18:31:50

https://register.epo.org/application?number=EP19805439